Um dos principais objetivos do Life4me+ - é prevenir novos casos de HIV e outras ISTs, hepatite C e tuberculose.

O aplicativo ajuda a estabelecer uma comunicação anônima entre médicos e pessoas soropositivas. A App permite que você organize convenientemente o seu horário de toma dos medicamentos e defina de uma forma personalizada os lembretes.

Todas as notícias / Janeiro 2019

Arquivo

✕

31 janeiro 2019

6658

Gilead found a partner for test a long-term ART

Gilead found a partner for test a long-term ART

According to press release of Lyndra Therapeutics, which specializes on development of long-term drugs, it managed to raise over $50 million as investments in its development. Gilead Sciences, a biotechnology company interested in a long-term ART market, was among the interested ...

29 janeiro 2019

6634

Refugees do not affect the spread of HIV in the EU, - WHO

Refugees do not affect the spread of HIV in the EU, - WHO

The World Health Organization has denied a widespread view of the impact of mass migration on the spread of HIV in the European Union. According to the analysis of several thousand documents submitted within the framework of the organization’s report this week, the rate ...

28 janeiro 2019

6896

HIV-positive women are more at risk of recurrent cervical cancer

HIV-positive women are more at risk of recurrent cervical cancer

Among women living with HIV, more often than among HIV-negative, there are cases of residual or recurring events after treatment of precancerous lesions of the cervix, it follows from the work published in January in Clinical Infectious Diseases.

25 janeiro 2019

6784

HIV positive status does not affect flu transmission

HIV positive status does not affect flu transmission

According to a study published in December in the Journal of Infectious Diseases, transmission of the seasonal flu virus was not directly related to HIV-positive status, despite the increased vulnerability to infection of people living with HIV.

24 janeiro 2019

8544

Bono: Western world risks losing the fight against HIV

Bono: Western world risks losing the fight against HIV

Speaking at a panel discussion at the World Economic Forum in Davos, well-known musician and founder of the foundation for fighting AIDS, Bono said that the world risks losing the fight against HIV infection due to inadequate assessment of their steps by governments of developed ...

23 janeiro 2019

7356

Scientists have proposed a fundamentally new way of blocking HIV reactivation in affected cells

Scientists have proposed a fundamentally new way of blocking HIV reactivation in affected cells

Most studies of HIV infection are currently centered around the treatment and prevention of the virus, writes the portal YaleNews. But until now, specialists know little about how the body resists HIV after infection.

23 janeiro 2019

7195

The reasons for the higher prevalence of HIV infection among black MSM have been established

The reasons for the higher prevalence of HIV infection among black MSM have been established

A group of American scientists conducted a study that showed that young black gays and bisexuals are more at risk of becoming infected with HIV than their white or Latin American peers, writes Aidsmap portal.

19 janeiro 2019

7412

Atripla as an ART of the first line was ineffective only in 6% of cases

Atripla as an ART of the first line was ineffective only in 6% of cases

An international group of experts conducted a study that showed for the first time how effective the drug Atripla (tenofovir / emtricitabine / efavirenz), used in high-income countries as first-line ART, is effective over the long term. The results of the evaluation were ...

18 janeiro 2019

7080

Efavirenz is absolutely safe for HIV-positive women during pregnancy

Efavirenz is absolutely safe for HIV-positive women during pregnancy

An analysis of 25,000 pregnancy cases of HIV-positive women from 2002 to 2015 by specialists at the University of Geneva. demonstrated that the incidence of birth defects among newborns after a mother took the drug efavirenz was not statistically different, and in some cases ...

17 janeiro 2019

6480

Scientists: test on CD4 before starting ART in poor countries could save thousands of lives

Scientists: test on CD4 before starting ART in poor countries could save thousands of lives

A pillar of public health in low- and middle-income countries on a resource-based approach to prescribing antiretroviral therapy for people diagnosed with HIV can save thousands of lives. These are the findings of a group of specialists from Washington University, published ...

1 2